Preclinical Characterization and Phase I Study of an Anti-HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies by Janku, Filip, Han, Sae-Won, Doi, Toshihiko, Amatu, Alessio, Ajani, Jaffer A, Kuboki, Yasutoshi, Cortez, Alex, Cellitti, Susan E, Mahling, Ping C, Subramanian, Kulandayan, Schoenfeld, Heidi A, Choi, Sarah M, Iaconis, Lori A, Lee, Lang Ho, Pelletier, Marc R, Dranoff, Glenn, Askoxylakis, Vasileios, Siena, Salvatore

Get full text